Saudi to test the effectiveness of plasma in treating COVID-19

, , ,

A number of Saudi health and research centers have launched a study to test therapeutic options to treat the coronavirus disease (COVID-19) by using plasma from recovered patients.

The study aims to test the effectiveness of plasma in treating advanced cases of the disease after taking blood components from those who are eligible and volunteered to participate in the study.

Plasma plays a critical part in the treatment of many serious health problems, as it contains antibodies that help the human body to recover.

Similar studies are being conducted globally as the world races to find a cure and treatment for COVID-19, that has infected over 3.5 million and caused a little over 240,000 fatalities worldwide.

Dr. Hani Al-Hashmi, director of the Oncology Center at King Fahd Specialist Hospital in Dammam, told Arab News that the study aims to reach therapeutic solutions based on solid medical studies.